Matches in SemOpenAlex for { <https://semopenalex.org/work/W2940903529> ?p ?o ?g. }
- W2940903529 endingPage "564" @default.
- W2940903529 startingPage "558" @default.
- W2940903529 abstract "Abstract Patients with chronic kidney disease are at increased risk of cardiovascular disease and this often manifests clinically like heart failure. Conversely, patients with heart failure frequently have reduced kidney function. The links between the kidneys and cardiovascular system are being elucidated, with blood pressure being a key risk factor. Patients with heart failure have benefitted from many trials which have now established a strong evidence based on which to base management. However, patients with advanced kidney disease have often been excluded from these trials. Nevertheless, there is little evidence that the benefits of such treatments are modified by the presence or absence of kidney disease, but more direct evidence among patients with advanced kidney disease is required. Neprilysin inhibition is the most recent treatment to be shown to improve outcomes among patients with heart failure. The UK HARP-III trial assessed whether neprilysin inhibition improved kidney function in the short- to medium-term and its effects on cardiovascular biomarkers. Although no effect (compared to irbesartan control) was found on kidney function, allocation to neprilysin inhibition (sacubitril/valsartan) did reduce cardiac biomarkers more than irbesartan, suggesting that this treatment might improve cardiovascular outcomes in this population. Larger clinical outcomes trials are needed to test this hypothesis." @default.
- W2940903529 created "2019-05-03" @default.
- W2940903529 creator A5002816008 @default.
- W2940903529 creator A5030243760 @default.
- W2940903529 creator A5070127648 @default.
- W2940903529 creator A5078477384 @default.
- W2940903529 creator A5086644818 @default.
- W2940903529 creator A5088900128 @default.
- W2940903529 date "2019-04-26" @default.
- W2940903529 modified "2023-10-01" @default.
- W2940903529 title "Chronic kidney disease, heart failure and neprilysin inhibition" @default.
- W2940903529 cites W1497461844 @default.
- W2940903529 cites W1570583414 @default.
- W2940903529 cites W1898108651 @default.
- W2940903529 cites W1970999603 @default.
- W2940903529 cites W1971300193 @default.
- W2940903529 cites W1972592757 @default.
- W2940903529 cites W1991662102 @default.
- W2940903529 cites W1994035387 @default.
- W2940903529 cites W2004511808 @default.
- W2940903529 cites W2015668150 @default.
- W2940903529 cites W2018536734 @default.
- W2940903529 cites W2019440040 @default.
- W2940903529 cites W2019663114 @default.
- W2940903529 cites W2035667813 @default.
- W2940903529 cites W2040557090 @default.
- W2940903529 cites W2051703838 @default.
- W2940903529 cites W2054007401 @default.
- W2940903529 cites W2057081385 @default.
- W2940903529 cites W2077571864 @default.
- W2940903529 cites W2083313568 @default.
- W2940903529 cites W2083403848 @default.
- W2940903529 cites W2094008805 @default.
- W2940903529 cites W2102365116 @default.
- W2940903529 cites W2102751959 @default.
- W2940903529 cites W2109064733 @default.
- W2940903529 cites W2111945961 @default.
- W2940903529 cites W2113698123 @default.
- W2940903529 cites W2117520342 @default.
- W2940903529 cites W2120939456 @default.
- W2940903529 cites W2125399797 @default.
- W2940903529 cites W2129015099 @default.
- W2940903529 cites W2130205752 @default.
- W2940903529 cites W2135521686 @default.
- W2940903529 cites W2143094666 @default.
- W2940903529 cites W2144652526 @default.
- W2940903529 cites W2148669301 @default.
- W2940903529 cites W2152072062 @default.
- W2940903529 cites W2155400583 @default.
- W2940903529 cites W2156754463 @default.
- W2940903529 cites W2160986394 @default.
- W2940903529 cites W2164705414 @default.
- W2940903529 cites W2167171402 @default.
- W2940903529 cites W2167760816 @default.
- W2940903529 cites W2167939344 @default.
- W2940903529 cites W2170664634 @default.
- W2940903529 cites W2198866495 @default.
- W2940903529 cites W2334371071 @default.
- W2940903529 cites W2427094903 @default.
- W2940903529 cites W2585382523 @default.
- W2940903529 cites W2609231773 @default.
- W2940903529 cites W2649240144 @default.
- W2940903529 cites W2770649031 @default.
- W2940903529 cites W2797845698 @default.
- W2940903529 cites W2804346271 @default.
- W2940903529 cites W2853535422 @default.
- W2940903529 cites W2898388822 @default.
- W2940903529 cites W2898498137 @default.
- W2940903529 cites W30493569 @default.
- W2940903529 cites W4362070830 @default.
- W2940903529 cites W52877415 @default.
- W2940903529 cites W75245760 @default.
- W2940903529 doi "https://doi.org/10.1093/ndt/gfz058" @default.
- W2940903529 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7139204" @default.
- W2940903529 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31028383" @default.
- W2940903529 hasPublicationYear "2019" @default.
- W2940903529 type Work @default.
- W2940903529 sameAs 2940903529 @default.
- W2940903529 citedByCount "31" @default.
- W2940903529 countsByYear W29409035292020 @default.
- W2940903529 countsByYear W29409035292021 @default.
- W2940903529 countsByYear W29409035292022 @default.
- W2940903529 countsByYear W29409035292023 @default.
- W2940903529 crossrefType "journal-article" @default.
- W2940903529 hasAuthorship W2940903529A5002816008 @default.
- W2940903529 hasAuthorship W2940903529A5030243760 @default.
- W2940903529 hasAuthorship W2940903529A5070127648 @default.
- W2940903529 hasAuthorship W2940903529A5078477384 @default.
- W2940903529 hasAuthorship W2940903529A5086644818 @default.
- W2940903529 hasAuthorship W2940903529A5088900128 @default.
- W2940903529 hasBestOaLocation W29409035291 @default.
- W2940903529 hasConcept C104826730 @default.
- W2940903529 hasConcept C126322002 @default.
- W2940903529 hasConcept C159641895 @default.
- W2940903529 hasConcept C164705383 @default.
- W2940903529 hasConcept C177713679 @default.
- W2940903529 hasConcept C181199279 @default.
- W2940903529 hasConcept C185592680 @default.